Business Wire

Smiths Detection Launches CORSYS: The Future of Integrated Security for Ports and Borders in the Palm of Your Hand

Del

Smiths Detection is proud to unveil its pioneering enterprise-level security command centre, CORSYS – a secure, cloud-based, digital ecosystem that integrates data from a vast array of devices and processes, to support critical ports and borders security.

CORSYS’ ability to consolidate information into a single command centre display eliminates the need for security operations managers to access multiple, independent bespoke systems to obtain the information they require.

The SaaS-based software product is a hardware-agnostic system that is fully mobile responsive/enabled. By allowing users to control their entire security operation from a single, secure window it supports real-time awareness and rapid decision-making. Following development, rigorous testing and extensive customer journey-mapping workshops have ensured CORSYS offers ease of use and the highest levels of security.

It has been developed specifically for Business to Government operations and will be officially unveiled at the World Customs Organization’s Global Technology and Innovation Forum in Japan this week (31 October - 2 November 2017).

“CORSYS uses the latest digital architecture – including stream analytics, machine learning; and augmented intelligence – to aggregate data from a customer’s stable of IoT devices, in order to assess anomalies, detect risks and improve outcomes,” said Smiths Detection’s Global Market Director for Ports & Borders, Tim Norton.

He added: “In a ports and borders application, CORSYS can provide an overall view of the entire port, as well as assessing every single container. It can view data from an electronic manifest and help customs administrators generate a risk profile for each container arriving at a port, using a combination of physical and data-driven tools. It also integrates smart CCTV and third-party data sources.”

CORSYS has been designed to help Customs Administrators identify anomalies, manage risks more effectively and increase duty collections to significantly improve overall operational performance.

CORSYS can integrate three aspects of an organisation’s security operations:

1. Devices: including screening and detection equipment; perimeter security; access control; surveillance equipment; and communications networks

2. Processes: including manifest examination; screening decision-making; physical inspection communications; and process flow (for containers/parcels), as well as maintenance planning and execution

3. Oversight tools: including asset management and performance dashboards

The CORSYS architecture is based on an open, hardware-agnostic platform designed with Microsoft Azure as its core SaaS delivery service. It is developed on globally accepted technology, with government-level disaster recovery, that is positioned for large-scale enterprises.

As Smiths Detection’s Tim Norton highlights: “The PROFILER application, for example, uses machine learning algorithms to determine the most efficient way to physically inspect targets – be that non-intrusive inspection (such as X-ray scanning), canine inspection or destuffing (unloading) the container. The ANALYSER+ application enhances the ability to recognise threats and contraband, while the DECISION CENTRE & DASHBOARD applications allow officers to monitor the entire flow of their security operations from a single window.”

Following its launch at the 2017 World Customs Organization’s Global Technology and Innovation Forum, CORSYS will be available to purchase in Q1 2018. To learn more, please visit www.corsys.com for the latest information.

About Smiths Detection

Smiths Detection is a global leader in threat detection and screening technologies for the military, air transportation, homeland security and emergency response sectors. Our experience and history across more than 40 years at the frontline, enables us to provide unrivalled levels of expertise to detect and identify constantly changing chemical, biological, radiological, nuclear and explosive threats, as well as weapons, contraband and narcotics.

Our goal is simple - to provide the security, peace of mind and freedom of movement upon which the world depends. For more information visit www.smithsdetection.com

Smiths Detection is part of Smiths Group, a global technology company listed on the London Stock Exchange. A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat and contraband detection, medical devices, energy and communications markets worldwide, employing more than 22,000 people in over 50 countries. For more information visit www.smiths.com.

Contact information

Smith Detection
Karen Kulinski
Director Communications and Marketing (EMEA)
+49 (0)611 9412 422
karen.kulinski@smithsdetection.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 13:55Pressemelding

Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’

Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 13:15Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk

Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 12:57Pressemelding

Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl

Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 08:00Pressemelding

Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di

FCC Grants LeoSat U.S. Market Access16.11.2018 06:00Pressemelding

LeoSat Enterprises, the dynamic young company which is launching a unique new data network comprised of a constellation of up to 108 low-earth-orbit communications satellites, has been awarded the authority by the U.S. Federal Communications Commission (FCC) to provide NGSO (non-geostationary satellite orbit) services in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181115005890/en/ LeoSat's Global Business Backbone in Space (Graphic: Business Wire) The increasing demand for business connectivity and with it, the need to move large quantities of data quickly and securely around the world, is fast outpacing the infrastructure in place to carry it. Existing networks are already carrying more than 1 Zeta Byte of traffic globally and this is set to grow exponentially. The FCC market access grant will allow LeoSat to address currently unmet demand for high-bandwidth, low-latency, high-security data transmissio

German Court Rules Huawei, ZTE Products Infringe AVC Patents16.11.2018 05:01Pressemelding

MPEG LA announced today that the District Court in Düsseldorf, Germany (“Landgericht Düsseldorf”) has ruled that Huawei Technologies Deutschland GmbH (“Huawei”) and ZTE Deutschland GmbH (“ZTE”) infringed patents of two patent holders in MPEG LA’s AVC Patent Portfolio License (“AVC License”) by using their technologies in mobile phones that implement the AVC/H.264 (MPEG-4 Part 10) Standard. The court also found that the license offered by the patent holders under those patents through the AVC License is fair, reasonable and nondiscriminatory. “The Landgericht Düsseldorf’s decision confirms the importance of respect for intellectual property, and offering everyone easy and affordable access to essential AVC technology under a single license is a cornerstone of the MPEG LA AVC License’s wide acceptance making that possible,” said Larry Horn, President and CEO of MPEG LA. “We continue to welcome Huawei and ZTE to join the nearly 2,000 Licensees who have entered into our AVC License.” Verdi